POVAL KOGYO Co., Ltd. (TYO:4247)

Verve Therapeutics Ratios and Metrics

Market cap in millions JPY. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 1, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	3,293	3,143	3,451	2,990	3,019	3,675
Market Cap Growth	-8.93%	-8.93%	15.42%	-0.96%	-17.85%	74.37%
Enterprise Value	2,499	2,805	2,433	1,706	1,942	2,679
Last Close Price	1250.00	1193.00	1268.97	1068.08	1043.16	1233.33
PE Ratio	41.17	39.29	18.66	11.68	10.82	17.42
PS Ratio	0.97	0.93	0.96	0.84	0.87	1.13
PB Ratio	0.58	0.55	0.60	0.54	0.56	0.71
P/TBV Ratio	0.58	0.55	0.61	0.54	0.57	0.72
P/FCF Ratio	137.22	130.96	-	63.62	18.30	-
P/OCF Ratio	6.82	6.51	7.57	14.04	9.65	11.14
EV/Sales Ratio	0.74	0.83	0.68	0.48	0.56	0.82
EV/EBITDA Ratio	6.53	7.32	5.48	3.33	3.92	5.99
EV/EBIT Ratio	10.46	11.74	7.65	4.64	5.24	8.30
EV/FCF Ratio	104.13	116.88	-	36.30	11.77	-
Debt / Equity Ratio	0.04	0.04	0.00	0.00	0.00	0.00
Debt / EBITDA Ratio	0.57	0.57	0.05	0.04	0.04	0.04
Debt / FCF Ratio	9.17	9.17	-	0.43	0.12	-
Asset Turnover	0.48	0.48	0.53	0.54	0.55	0.53
Inventory Turnover	1.97	1.97	2.08	2.18	2.29	2.11
Quick Ratio	1.97	1.97	2.48	3.17	2.78	2.76
Current Ratio	3.19	3.19	4.27	4.91	4.11	4.25
Return on Equity (ROE)	1.22%	1.22%	3.28%	4.70%	5.31%	4.23%
Return on Assets (ROA)	2.13%	2.13%	2.94%	3.49%	3.64%	3.26%
Return on Capital (ROIC)	2.56%	2.56%	3.52%	4.21%	4.39%	4.00%
Return on Capital Employed (ROCE)	3.90%	3.90%	5.10%	6.10%	6.40%	5.80%
Earnings Yield	2.43%	2.54%	5.36%	8.56%	9.24%	5.74%
FCF Yield	0.73%	0.76%	-8.63%	1.57%	5.46%	-1.03%
Dividend Yield	3.16%	3.19%	2.92%	3.37%	3.07%	2.43%
Payout Ratio	122.50%	122.50%	51.89%	37.89%	29.03%	37.44%
Buyback Yield / Dilution	-	-	-	-	0.00%	0.00%
Total Shareholder Return	3.16%	3.19%	2.92%	3.37%	3.07%	2.43%

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.